Brief: Paion Announces Clinical Development Progress With Remimazolam By Partner Hana Pharm In South Korea

PAION AG

08/10/2018 13:31

Oct 8 (Reuters) - PAION AG  PA8G.DE :
    * ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM
BY ITS
PARTNER HANA PHARM IN SOUTH KOREA
    * HANA PHARM SUCCESSFULLY COMPLETES PATIENT RECRUITMENT OF A
PHASE
III TRIAL IN GENERAL ANESTHESIA

Source text for Eikon:  ID:nEQ1gYjTLa 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))